Relief from malignant hypertension by treatment with captopril in a patient on maintenance hemodialysis.
作者信息
Witzgall H
出版信息
Klin Wochenschr. 1980 Sep 1;58(17):871-3. doi: 10.1007/BF01476998.
PMID:7003235
Abstract
A patient with end-stage renal disease due to malignant hypertension is described. Hypertension was resistant to hemodialysis. The orally active inhibitor of angiotensin-converting enzyme captopril (SQ 14.255; 2-D-methyl-3-mercaptopropanoyl-L-protein) dramatically lowered the elevated blood pressure both under ambulatory and dialysis conditions. No side effects were observed after 6 months' treatment. The effect of captopril could be described as a "biochemical nephrectomy".
摘要
相似文献
1
Relief from malignant hypertension by treatment with captopril in a patient on maintenance hemodialysis.
Klin Wochenschr. 1980 Sep 1;58(17):871-3. doi: 10.1007/BF01476998.
2
Successful acute and long-term treatment of renin-induced hypertension in two infants with captopril.卡托普利成功治疗两名婴儿肾素性高血压的急性和长期疗效
Eur J Pediatr. 1980 Dec;135(2):161-4. doi: 10.1007/BF00441635.
3
[Successful treatment of renal hypertension in a 2 1/2-year-old girl with the converting enzyme inhibitor captopril (author's transl)].
Monatsschr Kinderheilkd. 1980 Nov;128(11):724-6.
4
Captopril and salt subtraction to treat "uncontrollable" hypertension in haemodialysis patients.
Proc Eur Dial Transplant Assoc. 1979;16:610-7.
5
Effect of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive patients on hemodialysis.
Tohoku J Exp Med. 1982 May;137(1):21-31. doi: 10.1620/tjem.137.21.
6
[Long term treatment of resistant hypertension with captopril (author's transl)].
Nouv Presse Med. 1981 Apr 30;10(19):1565-9.
7
Hemodialysis-resistant hypertension: control with an orally active inhibitor of angiotensin-converting enzyme.
J Clin Endocrinol Metab. 1979 May;48(5):869-71. doi: 10.1210/jcem-48-5-869.
8
Captopril treatment in hypertensive dialysis patients.
Scand J Urol Nephrol. 1982;16(3):251-6. doi: 10.3109/00365598209179762.
9
[Increase of renal failure after treatment of malignant hypertension by captopril (author's transl)].卡托普利治疗恶性高血压后肾衰竭的增加（作者译）
Klin Wochenschr. 1980 Sep 1;58(17):897-9. doi: 10.1007/BF01477002.
10
Absence of blood-pressure lowering effect of captopril in anephric patients.卡托普利对无肾患者无降压作用。
Br Med J. 1980 Apr 19;280(6221):1067-8. doi: 10.1136/bmj.280.6221.1067.
本文引用的文献
1
Paper chromatographic systems for the separation of aldosterone, 18-hydroxycorticosterone, 18-hydroxydeoxycorticosterone, corticosterone and deoxycorticosterone.
J Chromatogr. 1980 Sep 26;198(1):70-5. doi: 10.1016/s0021-9673(00)81198-x.
2
Indomethacin (IND) inhibits an enhanced renin release following the captopril, SQ 14225, administration.
Life Sci. 1980 Feb 18;26(7):561-5. doi: 10.1016/0024-3205(80)90320-3.
3
Hypertension in end-stage renal disease.
N Engl J Med. 1969 May 1;280(18):978-81. doi: 10.1056/NEJM196905012801802.
4
Reaction constants of renin in juxtaglomerular apparatus and plasma renin activity after renal ischemia and hemorrhage.肾缺血和出血后肾小球旁器中肾素的反应常数及血浆肾素活性
Kidney Int. 1975 May;7(5):331-41. doi: 10.1038/ki.1975.46.
5
Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.卡托普利对高血压患者肾素 - 血管紧张素系统的阻断可导致醛固酮分泌持续减少、钾潴留和利钠作用。
Hypertension. 1979 May-Jun;1(3):274-80. doi: 10.1161/01.hyp.1.3.274.
6
Hemodialysis-resistant hypertension: control with an orally active inhibitor of angiotensin-converting enzyme.
J Clin Endocrinol Metab. 1979 May;48(5):869-71. doi: 10.1210/jcem-48-5-869.
7
Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.血管紧张素转换酶特异性抑制剂的设计：新型口服活性抗高血压药物
Science. 1977 Apr 22;196(4288):441-4. doi: 10.1126/science.191908.
Zotero 插件